Giuseppe Tavormina

Summary

Affiliation: Psychiatric Studies Centre
Location: Provaglio di Iseo, Italy
URL: www.censtupsi.org
Summary:
Psychiatrist
- President of "Psychiatric Studies Centre"
- General Secretary of "European Depression Association (EDA)" and "EDA Italia Onlus" (www.edaweb.eu)

Grants:
Senior Research Fellow of Bedforshire Centre-University of Cambridge (www.bcmhr-cu.org)
Publications:
1. Figar M, Marini F, Tavormina G, et al - "Percorsi dellurgenza in Psichiatria: lo psichiatra tra il comprendere e lagire" (Giornale Veneto di Scienze Mediche, 1992; 44: suppl 4: 39-45);
2. Tavormina G - "Il ruolo della Fluvoxamina nel disturbo bipolare dellumore di tipo misto" (Neuronius, 1999; 1: 3-4);
3. Tavormina G - "Variabilità di utilizzo del Citalopram e sua tollerabiltà" (Giornale Italiano di Psicopatologia, 2000; 6: suppl 1: 262);
4. Tavormina G - "Utilizzo della Gabapentina negli stati misti dei disturbi dellumore con disritmie allEEG" (Giornale Italiano di Psicopatologia, 2000; 6: suppl 1: 262-3);
5. Tavormina G - "Efficacy and tolerability of Mirtazapine in bipolar spectrum depression" (The International Journal of Neuropsychopharmacology, 2000; 3: suppl 1: 194);
6. Tavormina G - "Oxcarbazepine as a mood regulator: its efficacy, safety and tolerability vs Carbamazepine" (The International Journal of Neuropsychopharmacology, 2000; 3: suppl 1: 337);
7. Tavormina G - "Utilizzo del Risperidone nei gravi disturbi dell’umore dello spettro bipolare" (Giornale Italiano di Psicopatologia, 2001; 7: suppl 1: 235-6);
8. Tavormina G - "Bright light treatment for women’s mental health: four cases reports" (Archives of Women’s Mental Health, 2001; 3: suppl 2: 94);
9. Tavormina G, Corea S, Sirianni P, Tavormina M - “Mood or anxious diseases of the significant others of patients with mood or anxious diseases” (The World Journal of Biological Psychiatry, 2001; 2: suppl 1: 207);
10. Tavormina G - “Bright light therapy as an antidepressant modality” (The World Journal of Biological Psychiatry, 2001; 2: suppl 1: 341);
11. Tavormina G, Corea S - “Psychiatric Studies Centre” (The World Journal of Biological Psychiatry, 2001; 2: suppl 1: 376);
12. Tavormina G - “Efficacy of Fluvoxamine in depression of cyclothymic older patients” (International Psychogeriatrics, 2001; 13: suppl 2: 185);
13. Tavormina G - “Ropinirole as an antidepressant: its efficacy and tolerability” (Actas Espagnolas de Psiquiatria, 2001; 29: suppl 1: 306);
14. Tavormina G - “Variability of Mirtazapine utilization” (Actas Espagnolas de Psiquiatria, 2001; 29: suppl 1: 306).
15. Tavormina G - "Il Ropinirolo come un antidepressivo: sua efficacia e tollerabilità" (Giornale Italiano di Psicopatologia , 2002; 8: suppl 1: 199);
16. Tavormina G - “Citalopram efficacy in PAD and OCD disorders” (European Psychiatry, 2002; 17: suppl 1: 95);
17. Tavormina G, Corea S - “Il CEN.STU.PSI., Centro Studi Psichiatrici – Provaglio d’Iseo”, (Studi di Psichiatria, 2002; 4: 5);
18. Tavormina G - “Venlafaxine utilization in mood disorders with resistant depressive symptoms” (The World Journal of Biological Psychiatry, 2002; 3: suppl 1: 28);
19. Tavormina G, Corea S, Citron A - “Reboxetine utilization as add-on terapy to SSRI in treatment-resistant depression” (J Clin Psychiatry, 2002; 63:11, 1082);
20. Tavormina G - “Efficacia di Fluvoxamina in pazienti anziani ciclotimici affetti da depressione” (Medico e paziente, 2002; 8: suppl 1: 3-4);
21. Tavormina G, Corea S, Sirianni P, Tavormina M - “Disturbi dell’umore o d’ansia nei partners dei pazienti con disturbi dell’umore o d’ansia” (Journal on line, Psichiatria, 2002; 23: 4);
22. Tavormina G - “Utilizzo della Venlafaxina nei disturbi dell’umore con sintomatologia depressiva resistente” (Journal on line, Psichiatria, 2002; 24: 4);
23. Tavormina G - “Uso della Terapia della Luce in varie patologie psichiatriche” (Journal on line, Psichiatria, 2002; 25: 4);
24. Tavormina G - “L’Oxcarbazepina come regolatore dell’umore: sua efficacia e tolerabilità vs. la Carbamazepina” (Giornale Italiano di Psicopatologia, 2003; 9: suppl 1: 305);
25. Tavormina G, Corea S, Citron A - “Mood or anxious diseases of the significant others of psichiatric patients” (European Psychiatry, 2004; 19: suppl 1: 186);
26. Tavormina G - “Bright light therapy in various psychiatric diseases” (Psychiatriki, 2004; 15: suppl 1: 183);
27. Tavormina G, Costigliola V - “European Depression Day” (Psychiatriki, 2004; 15: suppl 1: 184);
28. Tavormina G -”Risperidone utilization in serious bipolar mood disorders” (European Psychiatry, 2005; 20: suppl 1: 142);
29. Tavormina G, Corea S, Citron A -”The prevalence of psychiatric disease in the significant others of patients with known mood and anxious disease” (Clinical Practice and Epidemiology in Mental Health 2005; 1:12; 02 Aug 2005);
30. Tavormina G - ”Depressione e ansia in gravidanza: ruolo della terapia della luce” (Giornale Italiano di Psicopatologia , 2006; 12: suppl 1: 411-412);
31. Zdanowicz N, Tavormina G, Agius M, et al -”Actual emergency in psychiatry: from everyday problems to crisis” (European Psychiatry, 2006; 21: suppl 1: 170-1);
32. Tavormina G -”Depression and anxiety during pregnancy: the role of light therapy” (European Psychiatry, 2007; 22: suppl 1: 66);
33. Agius M, Tavormina G – “Identifying and treating bipolar illness early” (BMJ, February 19th , 2007 );
34. Tavormina G, Agius M - “Need to improve diagnosis and treatment for bipolar disorder” (Br J Psych, 2007; 190: 189-191);
35. Agius M, Tavormina G, Zaman R, et al - “Developing primary care treatment of depression” (Br J General Practice, 2007; 57: 501-2);
36. Tavormina G, Agius M - “The high prevalence of the bipolar spectrum in private practice” (J Bipolar Dis: Rev & Comm, 2007; 6; 3: 19);
37. Tavormina G - “Bipolar spectrum diagnosis and social aspects of mood disorders: the European Depression Day project” (Psychiatria Danubina, 2007; 19: suppl 1: 6);
38. Tavormina G - “Light therapy in pregnant women with depression ad anxiety” (Psychiatria Danubina, 2007; 19: suppl 1: 58);
39. Tavormina G, Agius M - “A study of the incidence of bipolar spectrum disorders in a private psychiatric practice” (Psychiatria Danubina, 2007; 19: 4: 370-74);
40. Zdanowicz N, Tavormina G, Agius M - “Must the risk of side effects dictate pharmacological practices?” (European Psychiatry, 2008; 23: suppl 2: 171);
41. Agius M, Tavormina G, Zaman R, et al - “Under diagnosis of bipolar affective disorder in an English community mental health team” (European Psychiatry, 2008; 23: suppl 2: 224);
42. Agius M, Tavormina G - "The bipolar spectrum: do we need a single algorithm for affective disorder?"
(European Psychiatry, 2009; 24: suppl 1: P01-218);
43. Tavormina G - "Le Dipendenze nello Spettro Bipolare e i suoi aspetti psico-educazionali: La Giornata Europea sulla Depressione" (La Fenice, Journal of Addictions, 2009; 1:1-2; Aug 2009;
44. Tavormina G - “The bipolar spectrum diagnosis: the role of the temperaments” (Psychiatria Danubina, 2009; 21: 2: 160-161;
45. Tavormina G - “The temperaments and their role in early diagnosis of bipolar spectrum disorders” (Psychiatria Danubina, 2010; 22, suppl 1: 15-17);
46. Tavormina G – “The temperaments: its knowledge is a crucial way in early diagnosis of bipolar disorders” (European Psychiatry, 2011; 26: suppl 1: P01-199);
47. Tavormina G – “Are somatisations symptoms important evidence for an early diagnosis of bipolar spectrum mood disorders?” (Psychiatria Danubina, 2011; 23: suppl 1: 13-14).

Publications

  1. request reprint
    Tavormina G, Agius M. A study of the incidence of bipolar spectrum disorders in a private psychiatric practice. Psychiatr Danub. 2007;19:370-4 pubmed
    ..In particular, there is a large proportion of patients who suffer from Bipolar II illness. The consequences of this in the diagnosis and management of patients is discussed. ..
  2. Agius M, Aguis M, Murphy C, Win A, Zaman R, Tavormina G. Developing primary care treatment of depression. Br J Gen Pract. 2007;57:501-2 pubmed
  3. request reprint
    Tavormina G. An approach to treat bipolar disorders mixed states. Psychiatr Danub. 2016;28:9-12 pubmed
    ....
  4. request reprint
    Tavormina G, Franza F, Stranieri G, Juli L, Juli M. Clinical Utilisation and Usefullness of the Rating Scale of Mixed States, ("Gt-Msrs"): a Multicenter Study. Psychiatr Danub. 2017;29:365-367 pubmed
    ..This study is the second validation study of the "G.T. MSRS" rating scale, in order to demonstrate its usefullness. ..

Detail Information

Publications4

  1. request reprint
    Tavormina G, Agius M. A study of the incidence of bipolar spectrum disorders in a private psychiatric practice. Psychiatr Danub. 2007;19:370-4 pubmed
    ..In particular, there is a large proportion of patients who suffer from Bipolar II illness. The consequences of this in the diagnosis and management of patients is discussed. ..
  2. Agius M, Aguis M, Murphy C, Win A, Zaman R, Tavormina G. Developing primary care treatment of depression. Br J Gen Pract. 2007;57:501-2 pubmed
  3. request reprint
    Tavormina G. An approach to treat bipolar disorders mixed states. Psychiatr Danub. 2016;28:9-12 pubmed
    ....
  4. request reprint
    Tavormina G, Franza F, Stranieri G, Juli L, Juli M. Clinical Utilisation and Usefullness of the Rating Scale of Mixed States, ("Gt-Msrs"): a Multicenter Study. Psychiatr Danub. 2017;29:365-367 pubmed
    ..This study is the second validation study of the "G.T. MSRS" rating scale, in order to demonstrate its usefullness. ..